174 related articles for article (PubMed ID: 32106421)
1. Predictors of Hyperuricemia after Kidney Transplantation: Association with Graft Function.
Folkmane I; Tzivian L; Folkmane E; Valdmane E; Kuzema V; Petersons A
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32106421
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia in kidney transplant recipients with intact graft function.
Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
[TBL] [Abstract][Full Text] [Related]
4. Elderly renal transplant recipients and renal dysfunction: a risk factor for hyperuricemia.
Einollahi B; Einollahi H; Rostami Z
Exp Clin Transplant; 2011 Dec; 9(6):376-80. PubMed ID: 22142044
[TBL] [Abstract][Full Text] [Related]
5. Uric acid contributes to glomerular filtration rate deterioration in renal transplantation.
Kim KM; Kim SS; Yun S; Lee MS; Han DJ; Yang WS; Park JS; Park SK
Nephron Clin Pract; 2011; 118(2):c136-42. PubMed ID: 21150221
[TBL] [Abstract][Full Text] [Related]
6. Hyperuricemia in adult renal allograft recipients: prevalence and predictors.
Malheiro J; Almeida M; Fonseca I; Martins LS; Pedroso S; Dias L; Henriques AC; Cabrita A
Transplant Proc; 2012 Oct; 44(8):2369-72. PubMed ID: 23026595
[TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients.
Osadchuk L; Bashir MH; Tangirala B; Marcus RJ; Nashar K; Hussain SM; Sureshkumar KK
Exp Clin Transplant; 2014 Jun; 12(3):190-4. PubMed ID: 24907717
[TBL] [Abstract][Full Text] [Related]
8. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
9. Uric acid and transplantation.
Mazali FC; Mazzali M
Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
[TBL] [Abstract][Full Text] [Related]
10. Kidney Transplantation From Old Deceased Donors: Impact of Uric Acid Level-A Quarter-Century of Experience in One Transplant Center.
Magott-Procelewska M; Madziarska K; Boratynska M; Chudoba P; Lepiesza A; Mazanowska O; Zmonarski S; Madziarski M; Hap K; Klinger M
Transplant Proc; 2018; 50(6):1701-1704. PubMed ID: 30056885
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy.
Akalin E; Ganeshan SV; Winston J; Muntner P
Transplantation; 2008 Sep; 86(5):652-8. PubMed ID: 18791445
[TBL] [Abstract][Full Text] [Related]
12. Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.
Han M; Lee JP; Park S; Kim Y; Kim YC; Ahn C; Han DJ; Ha J; Jung IM; Lim CS; Kim YS; Kim YH; Oh YK
PLoS One; 2017; 12(5):e0176786. PubMed ID: 28467476
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia in pediatric renal transplant recipients.
Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A
Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of early-onset hyperuricemia in renal transplant recipients.
Chung BH; Kang SH; Hwang HS; Choi BS; Park CW; Kim YS; Kim JI; Moon IS; Yang CW
Nephron Clin Pract; 2011; 117(3):c276-83. PubMed ID: 20847570
[TBL] [Abstract][Full Text] [Related]
15. Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival.
Numakura K; Satoh S; Tsuchiya N; Saito M; Maita S; Obara T; Tsuruta H; Inoue T; Narita S; Horikawa Y; Kagaya H; Miura M; Habuchi T
Transplantation; 2012 Jul; 94(2):145-51. PubMed ID: 22728291
[TBL] [Abstract][Full Text] [Related]
16. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
[TBL] [Abstract][Full Text] [Related]
17. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
[TBL] [Abstract][Full Text] [Related]
18. Uric acid and allograft loss from interstitial fibrosis/tubular atrophy: post hoc analysis from the angiotensin II blockade in chronic allograft nephropathy trial.
Hart A; Jackson S; Kasiske BL; Mauer MS; Najafian B; Matas AJ; Spong R; Ibrahim HN
Transplantation; 2014 May; 97(10):1066-71. PubMed ID: 24503762
[TBL] [Abstract][Full Text] [Related]
19. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia after renal transplantation.
Kalantar E; Khalili N; Hossieni MS; Rostami Z; Einollahi B
Transplant Proc; 2011 Mar; 43(2):584-5. PubMed ID: 21440768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
